Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology,Immunology and Allergy
Link
http://link.springer.com/article/10.1007/s00005-014-0311-0/fulltext.html
Reference112 articles.
1. Akil H, Watson SJ, Young E et al (1984) Endogenous opioids: biology and function. Annu Rev Neurosci 7:223–255
2. Aozuka Y, Koizumi K, Saitoh Y et al (2004) Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16–BL6 melanoma cells orthotopically implanted into syngeneic mice. Cancer Lett 216:35–42
3. Bauvois B, Dauzonne D (2006) Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. Med Res Rev 26:88–130
4. Bhagwat SV, Lahdenranta J, Giordano R et al (2001) CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 97:652–659
5. Bisignani GJ, McLaughlin PJ, Ordille SD et al (1999) Human renal cell proliferation in tissue culture is tonically inhibited by opioid growth factor. J Urol 162:2186–2191
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Opiorphin: an endogenous human peptide with intriguing application in diverse range of pathologies;Inflammopharmacology;2024-08-20
2. A comprehensive review of the literature on CD10: its function, clinical application, and prospects;Frontiers in Pharmacology;2024-02-08
3. An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers;Cancer Research Communications;2023-09-29
4. Conjoint analysis of OPRPN and SMR3A protein expression as potential predictive biomarkers for head and neck squamous cell carcinoma after radiotherapy;Oncology Reports;2022-07-20
5. Role of opiorphin genes in prostate cancer growth and progression;Future Oncology;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3